tiprankstipranks
LakeShore Biopharma Achieves Nasdaq Compliance Milestone
Company Announcements

LakeShore Biopharma Achieves Nasdaq Compliance Milestone

LakeShore Biopharma (LSB) has released an update.

Don't Miss our Black Friday Offers:

LakeShore Biopharma has successfully regained compliance with Nasdaq’s minimum bid price requirement after its shares achieved a closing bid price of $1.00 or more for 11 consecutive days. This milestone resolves an earlier non-compliance issue and reflects positively on the company’s stock performance. Investors can now look forward to more stable trading conditions for the biopharmaceutical firm.

For further insights into LSB stock, check out TipRanks’ Stock Analysis page.

Related Articles
TipRanks Auto-Generated NewsdeskLakeShore Biopharma Advances PIKA Rabies Vaccine Approval
TheFlyLakeShore Biopharma initiates BLA submission to DRAP for PIKA rabies vaccine
TipRanks Auto-Generated NewsdeskLakeShore Biopharma Announces Leadership Transition
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App